Hypoxic Vasospasm Mediated by cIMP: When Soluble Guanylyl Cyclase Turns Bad

Journal of Cardiovascular Pharmacology

Volumn 65, Issue 6, 2015, Pages 545-548

  Gao, Yuansheng ^a   Chen, Zhengju ^b   Leung, Susan W S ^c   Vanhoutte, Paul M ^c,d  

^a PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

^b PEKING UNIVERSITY   (China)

^c UNIVERSITY OF HONG KONG   (Hong Kong)

^d UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

cIMP; hypoxia; nitric oxide; soluble guanylyl cyclase; vasoconstriction

Indexed keywords

CALCIUM; CYCLIC IMP; GUANYLATE CYCLASE; INOSINE TRIPHOSPHATE; NITRIC OXIDE; RHO KINASE; CELL RECEPTOR;

CEREBROVASCULAR ACCIDENT; CONFERENCE PAPER; CORONARY ARTERY DISEASE; ENZYME ACTIVATION; ENZYME ACTIVITY; HEART INFARCTION; HUMAN; HYPERTENSION; HYPOXIA; MYOFILAMENT; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; VASOCONSTRICTION; VASOSPASM; ANIMAL; ARTERIAL OCCLUSIVE DISEASES; CALCIUM SIGNALING; COMPLICATION; ENZYMOLOGY; METABOLISM; PATHOPHYSIOLOGY; SECOND MESSENGER; SPASM; VASCULAR ENDOTHELIUM; VASCULAR SMOOTH MUSCLE;

ANIMALS; ARTERIAL OCCLUSIVE DISEASES; CALCIUM SIGNALING; CYCLIC IMP; ENDOTHELIUM, VASCULAR; GUANYLATE CYCLASE; HUMANS; HYPOXIA; MUSCLE, SMOOTH, VASCULAR; RECEPTORS, CYTOPLASMIC AND NUCLEAR; RHO-ASSOCIATED KINASES; SECOND MESSENGER SYSTEMS; SOLUBLE GUANYLYL CYCLASE; SPASM; VASOCONSTRICTION;

EID: 84931577908     PISSN: 01602446     EISSN: 15334023     Source Type: Journal    
DOI: 10.1097/FJC.0000000000000167     Document Type: Conference Paper

References (36)

1. Vanhoutte PM. Effects of anoxia and glucose depletion on isolated veins of the dog. Am J Physiol. 1976;230:1261-1268.
2. De Mey JG, Vanhoutte PM. Heterogeneous behavior of the canine arterial and venous wall: importance of the endothelium. Circ Res. 1982;51: 439-447.
3. De Mey JG, Vanhoutte PM. Anoxia and endothelium-dependent reactivity of the canine femoral artery. J Physiol. 1983;335:65-74.
4. Rubanyi GM, Vanhoutte PM. Hypoxia releases a vasoconstrictor substance from the canine vascular endothelium. J Physiol. 1985;364:45-56.
5. Graeser T, Vanhoutte PM. Hypoxic contraction of canine coronary arteries: role of endothelium and cGMP. Am J Physiol. 1991;261:H1769-H1777.
6. Lin PJ, Pearson PJ, Schaff HV. Endothelium-dependent contraction and relaxation of the human and canine internal mammary artery: studies on bypass graft vasospasm. Surgery. 1991;110:127-134.
7. Pearson PJ, Lin PJ, Schaff HV, et al. Augmented endothelium-dependent constriction to hypoxia early and late following reperfusion of the canine coronary artery. Clin Exp Pharmacol Physiol. 1996;23:634-641.
8. Chan CK, Mak J, Gao Y, et al. Endothelium-derived NO, but not cyclic GMP, is required for hypoxic augmentation in isolated porcine coronary arteries. Am J Physiol Heart Circ Physiol. 2011;301: H2313-H2321.
9. Nuñez C, Victor VM, Martí M, et al. Role of endothelial nitric oxide in pulmonary and systemic arteries during hypoxia. Nitric Oxide. 2013;37: 17-27.
10. Liu H, Chen Z, Liu J, et al. Endothelium-independent hypoxic contraction of porcine coronary arteries may be mediated by activation of phosphoinositide 3-kinase/Akt pathway. Vascul Pharmacol. 2014;61: 56-62.
11. Chen Z, Zhang X, Ying L, et al. Cyclic IMP-synthesized by sGC as a mediator of hypoxic contraction of coronary arteries. Am J Physiol Heart Circ Physiol. 2014;307:H328-H336.
12. Gao Y, Vanhoutte PM. Tissues cIMPly do not lie. Naunyn Schmiedebergs Arch Pharmacol. 2014;387:901-903.
13. Waldman SA, Murad F. Cyclic GMP synthesis and function. Pharmacol Rev. 1987;39:163-196.
14. Friebe A, Koesling D. The function of NO-sensitive guanylyl cyclase: what we can learn from genetic mouse models. Nitric Oxide. 2009;21: 149-156.
15. Gao Y. The multiple actions of NO. Pflugers Arch. 2010;459:829-839.
16. Garthwaite J. New insight into the functioning of nitric oxide-receptive guanylyl cyclase: physiological and pharmacological implications. Mol Cell Biochem. 2010;334:221-232.
17. Beste KY, Burhenne H, Kaever V, et al. Nucleotidyl cyclase activity of soluble guanylyl cyclase α1β1. Biochemistry. 2012;51:194-204.
18. Bähre H, Danker KY, Stasch JP, et al. Nucleotidyl cyclase activity of soluble guanylyl cyclase in intact cells. Biochem Biophys Res Commun. 2014;443:1195-1199.
19. Beste KY, Spangler CM, Burhenne H, et al. Nucleotidyl cyclase activity of particulate guanylyl cyclase A: comparison with particulate guanylyl cyclases E and F, soluble guanylyl cyclase and bacterial adenylyl cyclases CyaA and edema factor. PLoS One. 2013;8:e70223.
20. Behmanesh M, Sakumi K, Abolhassani N, et al. ITPase-deficient mice show growth retardation and die before weaning. Cell Death Differ. 2009;16:1315-1322.
21. Sakumi K, Abolhassani N, Behmanesh M, et al. ITPA protein, an enzyme that eliminates deaminated purine nucleoside triphosphates in cells. Mutat Res. 2010;703:43-50.
22. Simone PD, Pavlov YI, Borgstahl GE. ITPA (inosine triphosphate pyrophosphatase): from surveillance of nucleotide pools to human disease and pharmacogenetics. Mutat Res. 2013;753:131-146.
23. Gribble FM, Loussouarn G, Tucker SJ, et al. A novel method for measurement of submembrane ATP concentration. J Biol Chem. 2000;275: 30046-30049.
24. Ferguson DR, Price RH. The production of cIMP by toad bladder, and its effects on transport of water and salt. FEBS Lett. 1973;34:207-212.
25. 2+ sensitivity of smooth muscle and nonmusclemyosin II: modulated by G proteins, kinases, and myosin phosphatase. Physiol Rev. 2003;83:1325-1358.
26. Gao Y, Portugal AD, Negash S, et al. Role of Rho kinases in PKG-mediated relaxation of pulmonary arteries of fetal lambs exposed to chronic high altitude hypoxia. Am J Physiol Lung Cell Mol Physiol. 2007;292:L678-L684.
27. Dhanakoti S, Gao Y, Nguyen MQ, et al. Involvement of cGMP-dependent protein kinase in the relaxation of ovine pulmonary arteries to cGMP and cAMP. J Appl Physiol (1985). 2000;88:1637-1642.
28. Qin X, Zheng X, Qi H, et al. cGMP-dependent protein kinase in regulation of basal tone and in nitroglycerin and nitric oxide induced relaxation in porcine coronary artery. Pflugers Arch. 2007;454:913-923.
29. Wolter S, Golombek M, Seifert R. Differential activation of cAMP- and cGMP-dependent protein kinases by cyclic purine and pyrimidine nucleotides. Biochem Biophys Res Commun. 2011;415:563-566.
30. Duong-Quy S, Bei Y, Liu Z, et al. Role of Rho-kinase and its inhibitors in pulmonary hypertension. Pharmacol Ther. 2013;137:352-364.
31. Seifert R. Is cIMP a second messenger with functions opposite to those of cGMP? Naunyn Schmiedebergs Arch Pharmacol. 2014;387:897-899.
32. Reinecke D, Burhenne H, Sandner P, et al. Human cyclic nucleotide phosphodiesterases possess a much broader substrate-specificity than previously appreciated. FEBS Lett. 2011;585:3259-3262.
33. Reinecke D, Schwede F, Genieser HG, et al. Analysis of substrate specificity and kinetics of cyclic nucleotide phosphodiesterases with N'-methylanthraniloyl-substituted purine and pyrimidine 3',5'-cyclic nucleotides by fluorescence spectrometry. PLoS One. 2013;8:e54158.
34. Fava C, Montagnana M, Favaloro EJ, et al. Obstructive sleep apnea syndrome and cardiovascular diseases. Semin Thromb Hemost. 2011; 37:280-297.
35. Khayat R, Patt B, Hayes D Jr. Obstructive sleep apnea: the new cardiovascular disease. Part I: obstructive sleep apnea and the pathogenesis of vascular disease. Heart Fail Rev. 2009;14:143-153.
36. Vanhoutte PM, Shimokawa H, Tang EH, et al. Endothelial dysfunction and vascular disease. Acta Physiol (Oxf). 2009;196:193-222.